Cargando…

Prolonged Remission of Major Depressive Disorder After Single Nitrous Oxide Inhalation Treatment

Detalles Bibliográficos
Autores principales:	Nagele, Peter, Brown, Frank, Bass, Victoria, Yohanna, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379369/ https://www.ncbi.nlm.nih.gov/pubmed/32765325 http://dx.doi.org/10.3389/fpsyt.2020.00692

Ejemplares similares

Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy
por: Zorumski, Charles F., et al.
Publicado: (2015)

Inhalation of Nitrous Oxide
Publicado: (1847)

Remission of symptoms is not equal to functional recovery: Psychosocial functioning impairment in major depression
por: Yang, Hao, et al.
Publicado: (2022)

Discovery and validation of acetyl-L-carnitine in serum for diagnosis of major depressive disorder and remission status through metabolomic approach
por: Lee, Seungyeon, et al.
Publicado: (2022)

The Prolongation of Nitrous Oxid Anesthesia
por: Paterson, Herbert J.
Publicado: (1898)

What is better for psychiatry: Titrated or fixed concentrations of nitrous oxide?
por: Gillman, Mark A.
Publicado: (2022)

SPECT findings on neuropsychiatric symptoms caused by nitrous oxide abuse
por: Wang, Li, et al.
Publicado: (2022)

Persistent Brain Connectivity Changes in Healthy Volunteers Following Nitrous Oxide Inhalation
por: Palanca, Ben Julian A., et al.
Publicado: (2023)

Differences in Perceptions of Major Depressive Disorder Symptoms and Treatment Priorities Between Patients and Health Care Providers Across the Acute, Post-Acute, and Remission Phases of Depression
por: Baune, Bernhard T., et al.
Publicado: (2019)

Lipidomics in Major Depressive Disorder
por: Walther, Andreas, et al.
Publicado: (2018)

High Kynurenine (a Tryptophan Metabolite) Predicts Remission in Patients with Major Depression to Add-on Treatment with Celecoxib
por: Krause, Daniela, et al.
Publicado: (2017)

Death from the Inhalation of Nitrous Oxide Gas
por: Purcell, W. J.
Publicado: (1872)

Death Following the Inhalation of Nitrous Oxide Gas
Publicado: (1873)

The Anesthetic and Asphyxiating Effects of Nitrous-Oxid Inhalation
por: Thomas, J. D.
Publicado: (1896)

Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated With Antidepressant Efficacy in Major Depressive Disorder
por: Xin, Juncai, et al.
Publicado: (2020)

Eye Movement Abnormalities in Major Depressive Disorder
por: Takahashi, Junichi, et al.
Publicado: (2021)

Cortical Inhibition and Plasticity in Major Depressive Disorder
por: Castricum, Jesminne, et al.
Publicado: (2022)

The roles of extracellular vesicles in major depressive disorder
por: Li, Ying, et al.
Publicado: (2023)

Identifying circulating biomarkers for major depressive disorder
por: Zhang, En, et al.
Publicado: (2023)

quality of remission in the major depressive disorder
por: Chebli, H., et al.
Publicado: (2023)

Exploration of Major Cognitive Deficits in Medication-Free Patients With Major Depressive Disorder
por: Liu, Jin, et al.
Publicado: (2019)

Combination of Nitrous Oxide with Isoflurane or Scopolamine for Treatment-resistant Major Depression
por: Yang, Chun, et al.
Publicado: (2015)

Storytelling and training to advance individual recovery skills (STAIRS). A feasibility study of a blended program to support personal recovery among patients with a major depressive disorder in remission
por: Wedema, David, et al.
Publicado: (2022)

The Functional Anatomy of Psychomotor Disturbances in Major Depressive Disorder
por: Liberg, Benny, et al.
Publicado: (2015)

The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
por: Cao, Bing, et al.
Publicado: (2019)

Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder
por: Zuckerman, Hannah, et al.
Publicado: (2018)

Review of Abnormal Self-Knowledge in Major Depressive Disorder
por: Lou, Yixue, et al.
Publicado: (2019)

The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder
por: Nugent, Allison C., et al.
Publicado: (2020)

Gender Differences in Dysfunctional Attitudes in Major Depressive Disorder
por: Qin, Xuemei, et al.
Publicado: (2020)

Pineal Gland Volume in Major Depressive and Bipolar Disorders
por: Takahashi, Tsutomu, et al.
Publicado: (2020)

Glutamate and GABA Homeostasis and Neurometabolism in Major Depressive Disorder
por: Sarawagi, Ajay, et al.
Publicado: (2021)

Histamine and histamine receptors: Roles in major depressive disorder
por: Qian, Hong, et al.
Publicado: (2022)

Mapping Inter-individual Functional Connectivity Variability in TMS Targets for Major Depressive Disorder
por: Harita, Shreyas, et al.
Publicado: (2022)

Alterations of Plasma Lipids in Adult Women With Major Depressive Disorder and Bipolar Depression
por: Zhang, Ting, et al.
Publicado: (2022)

Enlarged cross-sectional area of the left vagus nerve in patients with major depressive disorder
por: Schreiber, Lisa Sofie, et al.
Publicado: (2023)

Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder
por: Muscatello, Maria Rosaria Anna, et al.
Publicado: (2019)

Biochemical and Endocrine Parameters for the Discrimination and Calibration of Bipolar Disorder or Major Depressive Disorder
por: Zhu, Yuncheng, et al.
Publicado: (2022)

Repeated Nitrous Oxide Exposure Exerts Antidepressant-Like Effects Through Neuronal Nitric Oxide Synthase Activation in the Medial Prefrontal Cortex
por: Liu, Wei, et al.
Publicado: (2020)

A Real-World, Prospective, Multicenter, Single-Arm Observational Study of Duloxetine in Patients With Major Depressive Disorder or Generalized Anxiety Disorder
por: Szekeres, Gyorgy, et al.
Publicado: (2021)

Pneumomediastinum Secondary to Barotrauma after Recreational Nitrous Oxide Inhalation
por: Jeddy, H., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t0bnct27s229ah8e3sja2tp7ok